These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29892782)

  • 1. Tumor budding and human chorionic gonadotropin-β expression correlate with unfavorable patient outcome in colorectal carcinoma.
    Konishi Y; Kawamata F; Nishihara H; Homma S; Kato Y; Tsuda M; Kohsaka S; Einama T; Liu C; Yoshida T; Nagatsu A; Tanino M; Tanaka S; Kawamura H; Kamiyama T; Taketomi A
    Med Oncol; 2018 Jun; 35(7):104. PubMed ID: 29892782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chorionic Gonadotropin-β Modulates Epithelial-Mesenchymal Transition in Colorectal Carcinoma Metastasis.
    Kawamata F; Nishihara H; Homma S; Kato Y; Tsuda M; Konishi Y; Wang L; Kohsaka S; Liu C; Yoshida T; Tanino M; Tanaka S; Kawamura H; Kamiyama T; Taketomi A
    Am J Pathol; 2018 Jan; 188(1):204-215. PubMed ID: 29037859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B Subunit of Human Chorionic Gonadotropin Promotes Tumor Invasion and Predicts Poor Prognosis of Early-Stage Colorectal Cancer.
    Li J; Yin M; Song W; Cui F; Wang W; Wang S; Zhu H
    Cell Physiol Biochem; 2018; 45(1):237-249. PubMed ID: 29357321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
    Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
    Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor budding at the invasive front of colorectal cancer may not be associated with the epithelial-mesenchymal transition.
    Yamada N; Sugai T; Eizuka M; Tsuchida K; Sugimoto R; Mue Y; Suzuki M; Osakabe M; Uesugi N; Ishida K; Otsuka K; Matsumoto T
    Hum Pathol; 2017 Feb; 60():151-159. PubMed ID: 27836787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue expression of human chorionic gonadotropin beta predicts outcome in colorectal cancer: a comparison with serum expression.
    Lundin M; Nordling S; Lundin J; Alfthan H; Stenman UH; Haglund C
    Int J Cancer; 2001 Jan; 95(1):18-22. PubMed ID: 11241305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined epithelial marker analysis of tumour budding in stage II colorectal cancer.
    Slik K; Blom S; Turkki R; Välimäki K; Kurki S; Mustonen H; Haglund C; Carpén O; Kallioniemi O; Korkeila E; Sundström J; Pellinen T
    J Pathol Clin Res; 2019 Jan; 5(1):63-78. PubMed ID: 30358171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with Stage II/III colorectal cancer.
    Roseweir AK; Kong CY; Park JH; Bennett L; Powell AGMT; Quinn J; van Wyk HC; Horgan PG; McMillan DC; Edwards J; Roxburgh CS
    Int J Cancer; 2019 Jan; 144(1):150-159. PubMed ID: 29992570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and diagnostic significance of tumor budding associated with β-catenin expression in submucosal invasive colorectal carcinoma.
    Umemura K; Takagi S; Shimada T; Masuda T; Shiga H; Takahashi S; Takahashi S; Kinouchi Y; Shibuya D; Shimosegawa T
    Tohoku J Exp Med; 2013 Jan; 229(1):53-9. PubMed ID: 23238650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancer.
    Oshiro R; Yamamoto H; Takahashi H; Ohtsuka M; Wu X; Nishimura J; Takemasa I; Mizushima T; Ikeda M; Sekimoto M; Matsuura N; Doki Y; Mori M
    Cancer Sci; 2012 Jun; 103(6):1155-64. PubMed ID: 22404718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
    Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
    Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
    Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
    Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
    Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
    Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
    Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H
    World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HtrA3 stromal expression is correlated with tumor budding in stage II colorectal cancer.
    Forse CL; Rahimi M; Diamandis EP; Assarzadegan N; Dawson H; Grin A; Kennedy E; O'Connor B; Messenger DE; Riddell RH; Kirsch R; Karagiannis GS
    Exp Mol Pathol; 2017 Aug; 103(1):94-100. PubMed ID: 28716573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
    Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
    Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HspB5 correlates with poor prognosis in colorectal cancer and prompts epithelial-mesenchymal transition through ERK signaling.
    Li Q; Wang Y; Lai Y; Xu P; Yang Z
    PLoS One; 2017; 12(8):e0182588. PubMed ID: 28796798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer.
    Wei JL; Fu ZX; Fang M; Guo JB; Zhao QN; Lu WD; Zhou QY
    Oncol Rep; 2015 Mar; 33(3):1349-57. PubMed ID: 25572852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.